• Title/Summary/Keyword: Adenocarcinoma of the lung

Search Result 628, Processing Time 0.026 seconds

Pulmonary Nodular Lymphoid Hyperplasia (폐 결절성 림프구양 증식증)

  • Koo, Hyeon-Kyoung;Kim, Seo-Yun;Park, Sung-Soo;Lee, Yeon-Joo;Lee, Ji-Yeon;Chung, Jin-Haeng;Lee, Jae-Ho;Lee, Choon-Taek;Yoon, Ho-Il
    • Tuberculosis and Respiratory Diseases
    • /
    • v.69 no.3
    • /
    • pp.212-216
    • /
    • 2010
  • Nodular lymphoid hyperplasia is a very rare benign disease and usually shows consolidation on chest X-ray with symptoms of pneumonia due to the proliferation of lymphoid cells in the lung parenchyma. It is common for patients to be diagnosed with pneumonia and treated with antibiotics, but patients often enter a cycle of repeated improvement, followed by aggravation of symptoms. At this point, surgical diagnostic tools are considered in order to differentiate between malignant disease and interstitial lung disease. Here, we report 2 cases of patients with nodular lymphoid hyperplasia and review the associated references.

Comparative Cytotoxic Activities of Various Ginsengs on Human Cancer Cell Lines

  • Sung Ryong Ko;You
    • Journal of Ginseng Research
    • /
    • v.22 no.1
    • /
    • pp.18-21
    • /
    • 1998
  • Comparative cytotoxic activities of petroleum ether soluble fraction from various ginsengs of Panax species were evaluated using A549 (human lung adenocarcinoma) and SK-OV-3(human ovary carcinoma) cancer cell lines. Korean red ginseng, Korean white ginseng, American ginseng and Canadian ginseng were found to show more potent cytotoxicitles on A549 and SK-OV-3 cell lines than Chinese red ginseng, Japanese red ginseng and Sanchi ginseng. It is noteworthy that especially, red ginseng prepared from the root of Panax ginseng cultivated in Korea shows relatively stronger cytotoxic activities than those cultivated in China and Japan.

  • PDF

Lobectomy with Video-Assisted Thoracoscopy - 4Cases Report - (비디오 흉강경을 이용한 폐엽절제술;4례 보고)

  • 윤용한
    • Journal of Chest Surgery
    • /
    • v.26 no.3
    • /
    • pp.236-240
    • /
    • 1993
  • Video thoracoscopic surgery is a new modality that gains acceptance rapidly from thoracic surgeons. We have experienced two left lower lobectomies, one left upper lobectomy & one right upper lobectomy with using video thoracoscopy for the four patients with lung parenchymal disease from July 1992 to February 1993. The post-operative courses were uneventful. The final pathologic diagnosis were sclerosing hemangioma, adenocarcinoma, bronchiectasis, leiomyoma & the post-operative courses were short. These patients needed less analgesics because postoperative pain was reduced markedly, and hospitalization was shortened due to rapid recovery. We would like to prefer video thoracoscopic lobectomy to the lobectomy through standard thoracotomy in uncomplicated patients with simple pulmonary parenchymal diseases.

  • PDF

Monitoring microRNAs Using a Molecular Beacon in CD133+/CD338+ Human Lung Adenocarcinoma-initiating A549 Cells

  • Yao, Quan;Sun, Jian-Guo;Ma, Hu;Zhang, An-Mei;Lin, Sheng;Zhu, Cong-Hui;Zhang, Tao;Chen, Zheng-Tang
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.1
    • /
    • pp.161-166
    • /
    • 2014
  • Lung cancer is the most common causes of cancer-related deaths worldwide, and a lack of effective methods for early diagnosis has greatly impacted the prognosis and survival rates of the affected patients. Tumor-initiating cells (TICs) are considered to be largely responsible for tumor genesis, resistance to tumor therapy, metastasis, and recurrence. In addition to representing a good potential treatment target, TICs can provide clues for the early diagnosis of cancer. MicroRNA (miRNA) alterations are known to be involved in the initiation and progression of human cancer, and the detection of related miRNAs in TICs is an important strategy for lung cancer early diagnosis. As Hsa-miR-155 (miR-155) can be used as a diagnostic marker for non-small cell lung cancer (NSCLC), a smart molecular beacon of miR-155 was designed to image the expression of miR-155 in NSCLC cases. TICs expressing CD133 and CD338 were obtained from A549 cells by applying an immune magnetic bead isolation system, and miR-155 was detected using laser-scanning confocal microscopy. We found that intracellular miR-155 could be successfully detected using smart miR-155 molecular beacons. Expression was higher in TICs than in A549 cells, indicating that miR-155 may play an important role in regulating bio-behavior of TICs. As a non-invasive approach, molecular beacons could be implemented with molecular imaging to diagnose lung cancer at early stages.

Fine Needle Aspiration Cytology of Atypical Carcinoid Tumor of the Lung - 2 Cases Report - (폐의 비정형 유암종의 세침흡인 세포학적 소견 - 2예 보고 -)

  • Lee, Youn-Soo;Park, Gyeong-Sin;Choi, Young-Jin;Kang, Seok-Jin;Kim, Byung-Kee;Shim, Sang-In
    • The Korean Journal of Cytopathology
    • /
    • v.8 no.1
    • /
    • pp.76-82
    • /
    • 1997
  • Two cases of pulmonary atypical carcinoid tumor were diagnosed by fine needle aspiration cytology. Although the cytologic features of atypical carcinoid tumor have been relatively well described, it is easy to confuse atypical carcinoid tumor with typical carcinoid tumor, small cell carcinoma and adenocarcinoma of the lung. Atypical carcinoid tumor has been recognized as a distinct variant of pulmonary neuroendocrine carcinoma, with characteristic histopathologic and clinical features that separate it from both carcinoid and small cell carelnoma. The distinction of atypical carcinoid tumor from small cell carcinoma has important prognostic and therapeutic implications. The cytologic characteristics of atypical carcinoid tumor included polygonal to fusiform cells with a variable amount of lacy cytoplasm, oval nuclei with coarsely dispersed chromatin and frequent nucleoli, and mild pleomorphism. The malignant cells were arranged either in acinus-like clusterg or in epithelial sheets.

  • PDF

Clinical Evaluation of Primary Lung Cancer (폐암의 임상적 고찰)

  • 이양삼
    • Journal of Chest Surgery
    • /
    • v.4 no.1
    • /
    • pp.25-34
    • /
    • 1971
  • We observed 88 csses of primary lung cancer clinically and statistically, which had been experienced at the dept. of thoracic surgery, St. Mary's Hospital, Catholic Medical College, during the period of 7 years from January, 1964 to December, 1970. The results obtained were as follows: 1) Peak incidence of age was from 5th decade to 7th decade (86.4%), the youngest being 25 and the oldest 76. The ratio of male to female was 4.9: 1. 2) Squamous cell carcinomas showed high resectability (68.7%) and short clinical duration (188 days). Adenocarcinoma and undifferentiated carcinoma showed low resectability (33.3%, 36.4%) in spite of the more shorter clinical duration(120 days, 112 days, respectively) than squamaus cell carcinoma. 3) Positivity (above class III) in brochocopic cytology was 70.3%, and 44.8% in fresh sputum cytology. 4) Other combined pulmonary diseases (emphysema. chronic bronchitis) were noted in about one half of bronchographied 66 cases and which were considered as factors to contribute ventilatory function of lung. 5) Among 88 cases, twelve cases refused operation and 34 cases(44.7%) were operated. Seventeen cases(22.3%) out of the 34 thoracotomies were resected, 7 with lobectomy and 10 with pneumonectomy and remaining 17 cases were unresectable. 6) Histopathological findiugs of resected 17 cases were squamous cell carcinomas (11 cases), adenocarcinoll1a(1 case), undifferentiated carcinumas (4 cases) and undetermined carcinoma(l case). 7) There's no opelative mortality. Among resected 17 cases, [; cases are still alive(4 years, 3 years & 2 mo, 2 yearo, 13 mo., respectively), 7 case were expired (3 of these from remote metastasis), and remaining 5 cases were unable to follow up.

  • PDF

Clinical Evaluation of Primary Lung Cancercancer (폐암의 임상적 고찰)

  • Kim, Gong-Su;Gu, Ja-Hong;Kim, Su-Seong
    • Journal of Chest Surgery
    • /
    • v.14 no.4
    • /
    • pp.324-330
    • /
    • 1981
  • This is a clinical evaluation of 43 primary lung cancer partients who were admitted at Chest Surgery department of Jeonbug National University Hospital from January 1975 to June 1980. The ratio of male to female was 13: 1 and the age at the time of diagnosis is peak during fourth and fifth decade. The major symptoms were cough, chest pain or discomfort, bloody sputum, and dyspnea. Histological diagnosis was squamous cell carcinoma in 30%, undifferentiate cell carcinoma in 23%, adenocarcinoma in 7%, alveolar cell carcinoma in 9% and undetermined histologic type in 30%. The most frequently involved lobe of primary lung cancer was both upper lobe bronchus and the next was stem bronchus. Only six among the 43 cases who had sputum cytology were positive for malignant cell and eleven among the 16 cases who had bronch oscopy perform were histologically malignancy. Among 43 cases, 15 cases were inoperable, 5 cases refused to operation and the operation was per. formed in 23 cases. Seventeen of the 23 cases with operation had resection, 6 with pneumonectomy, 9 with lobectomy and 2 with partial resection, and the others were unresectable.

  • PDF

Incidentally Founded Biphasic Pulmonary Blastoma - A case report - (우연히 발견된 이상성 폐모세포종 -1 증례-)

  • Kim, Nam-Hoon;Keum, Dong-Yoon;Kim, Joo-Heon;Park, Mee-Ja
    • Tuberculosis and Respiratory Diseases
    • /
    • v.50 no.5
    • /
    • pp.641-644
    • /
    • 2001
  • Pulmonary blastoma is a family of tumors in which the glands or mesenchyme composing the neoplasm are primitive or embryonic in appearance. There are three subtypes, which include well differentiated fetal adenocarcinoma (pulmonary endodermal tumor), biphasic pulmonary blastoma, and cystic and pleuropulmonary blastomas in children. Among them, biphasic pulmonary blastoma is a primary malignancy of the lung originating from multipotential pulmonary blastema including both the malignant fetal epithelial and mesenchymal components. These make up 0.25 to 0.5 percent of all primary malignant lung tumors. This tumor is usually symptomatic and appears as a large, solitary peripheral mass, with a tendency to favor the upper lobe. Here we report a case where a small sized asymptomatic peripheral lung mass was diagnosed as a biphasic pulmonary blastoma, prior to the operation, A subsequent percutaneous needle biopsy was performed, which revealed features of a large cell neuroendocrine tumor. In addition, a review of the relevant literature is provided.

  • PDF

Pericardial Tumor: 14 cases (심낭종양[14례])

  • Park, Hee-Chul;Lee, Hong-Kyun
    • Journal of Chest Surgery
    • /
    • v.15 no.1
    • /
    • pp.118-123
    • /
    • 1982
  • Fourteen cases of pericardia I tumor were clinically experienced from June 1966 to July 1981, for 15 years in St. Mary's Hospital, Department of Thoracic and Cardiovascular Surgery, Catholic Medical College. There were three primary tumors of the pericardium, liposarcoma, teratoma and malignant mesothelioma, and 11 metastatic pericardial tumors. In metastatic pericardial tumors, eight were originated from the lung, one was breast, and the other two cases were unknown origin. There were 6 adenocarcinoma, one small cell carcionoma ~nd one alveolar cell carcinoma in 8 cases from the lung, and 5 male and 3 female patients were composed the metastatic pericardial cancer from the lung. In clinical symptoms were dyspnea in all cases, and 9 cases had the generalized edema and enlarged liver size. Six patients had been operated, three of the primary pericardial tumor and three of metastatic pericardial tumor. Two of the primary tumors were cured satisfactorily by the mass removal, but one died due to cardiac arrest at postoperative one day. In metastatic tumors, operation were performed as two pericardial window formation and one left lower lobectomy with pericardial fenestration, but one was died in second operative day. Other nine metastatic tumors were diagnosed by needle biopsy in one case and by cell block of effusion in eight cases.

  • PDF

A Case of Non-Small Cell Lung Carcinoma Patient Who Improved Skin Rash Due to Olmutinib by Administration of Nobongsangki-Jeong (노봉상기정을 투여하여 Olmutinib으로 인한 피부염이 호전된 4기 비소세포성 폐암 환자 1례)

  • Choi, You-Na;Kim, Jeehye;Bae, Kyeore;Cho, Chong-kwan;Yoo, Hwa-Seung
    • Journal of Korean Traditional Oncology
    • /
    • v.22 no.1
    • /
    • pp.13-22
    • /
    • 2017
  • Objective: The purpose of this study is to report the effect of Nobongsangki-Jeong on skin rash caused by Olmutinib. Methods: A female Non-Small cell lung carcinoma patient (Adenocarcinoma, Stage IV, Epidermal Growth Factor Receptor positive) suffered from skin rash due to the side effect of Olmutinib administration. She was treated with Nobongsangki-Jeong for the symptom management for 14 days. The clinical outcomes were measured by numeric rating scale (NRS) and National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 4.03. Results: After treatment, skin rash was improved from NRS 5 to 1. Pruritus and pain of skin were improved from NCI-CTCAE grade 2 to 1. Conclusion: This case study suggests that Nobongsangki-Jeong may have the efficacy for the treatment of skin rash caused by Olmutinib.